... These include: Adalimumab-adbm (Cyltezo) — The only interchangeable biosimilar approved so far Adalimumab-afzb (Abrilada) Adalimumab-atto (Amjevita) Adalimumab-bwwd (Hadlima) Adalimumab-fkjp (Hulio) Adalimumab-adaz (Hyrimoz) Adalimumab-aqvh (Yusimry) Researchers have at least three more biosimilars in the works, offering people with PsA several treatment ...
... These include: Adalimumab-adbm (Cyltezo) — The only interchangeable biosimilar approved so far Adalimumab-afzb (Abrilada) Adalimumab-atto (Amjevita) Adalimumab-bwwd (Hadlima) Adalimumab-fkjp (Hulio) Adalimumab-adaz (Hyrimoz) Adalimumab-aqvh (Yusimry) Researchers have at least three more biosimilars in the works, offering people with PsA several treatment ...